secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABEONA THERAPEUTICS INC. (ABEO)
CIK:        0000318306
Form:       8-K
Filed at:   2024-05-03T23:59:59+00:00
Accession:  0001493152-24-017768
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Abeona Therapeutics prices $75M underwritten offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Offering: 12,285,056 common shares at $4.07/share and 6,142,656 pre-funded warrants at $4.0699 each.
- Gross proceeds ~$75M; net proceeds ~$70.2M after underwriting discounts and expenses.
- Closing expected May 7, 2024; Stifel is sole bookrunner.
- Proceeds to fund BLA resubmission and commercialization of pz-cel, plus working capital.
- New and existing investors participating include Adage Capital, Janus Henderson, Nantahala, Suvretta, Vivo Capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318306/000149315224017768/0001493152-24-017768-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318306/000149315224017768/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-017768

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer